Tool

Dose-escalation cost visualizer

Dose-tiered pricing means your monthly cost is a staircase, not a number. Enter your provider's price at each tier and how long you expect to spend there; the visualizer shows the staircase, the cumulative total, and the gap between the advertised first step and your actual average.

Visualizer

Your provider's tiers. Add or clear rows as your schedule requires; a tier with 0 months is skipped. Prices are whatever your provider charges at that tier — check whether yours is dose-flat before assuming it isn't.
TierPrice ($/month)Months at tier (0–12)
Tier 1 (starting dose)
Tier 2
Tier 3
Tier 4 (maintenance)

What the labels say about escalation

Escalation is not a marketing invention — it's how these drugs are labeled. The Zepbound label directs starting at 2.5 mg once weekly for four weeks, then 5 mg, increasing in 4-week steps as directed [1]; the 2.5 mg dose is for initiation and is not approved as a maintenance dosage [2]; maintenance dosages are 5, 10, or 15 mg weekly [3]. The pricing consequence: any plan priced per dose tier guarantees your cost rises during exactly the months marketing calls "from $X". Whetheryour provider prices per tier is a fact to check, not assume — some price flat across doses, which this tool represents as identical tier prices.

Assumptions

Cumulative cost = sum over tiers of (price × months); average = total ÷ total months. The tool assumes you progress through tiers in order and stay the months you enter — real titration is clinician-directed and tolerability-dependent, so treat the output as a budget scenario, not a schedule. Membership fees, labs, and shipping are excluded; add them with thetotal-cost calculator. Dose decisions belong to your clinician; this page only does the arithmetic on prices you enter.

Sources

  1. ZEPBOUND (tirzepatide) US Prescribing Information — FDA-approved product labelling, captured 2026-07-24Primary source linked
  2. ZEPBOUND (tirzepatide) US Prescribing Information — FDA-approved product labelling, captured 2026-07-24Primary source linked
  3. ZEPBOUND (tirzepatide) US Prescribing Information — FDA-approved product labelling, captured 2026-07-24Primary source linked

Cite this page

GLP Ranked. "Dose-escalation cost visualizer." Updated 2026-07-24. https://glpranked.com/tools/dose-escalation-cost-visualizer/

GLP Ranked. "Dose-escalation cost visualizer." Updated 2026-07-24. https://glpranked.com/tools/dose-escalation-cost-visualizer/